About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials in San Diego | 138 Studies

Clinical Trials LymphomaSan Diego

Lymphoma Clinical Trials in San Diego

Find 138 clinical trials for lymphoma near San Diego, California. Connect with research centers in your area.

All Lymphoma trials nationwide All trials in San Diego

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 138 trials

Active not recruitingBlinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic LeukemiaThis phase II trial studies the side effects and how well blinatumomab and combination chemotherapy or dasatinib, prednisone, and blinatumomab work in treating older patients with…NCT02143414·Birmingham, Alabama and 194 others

Lymphoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedInotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic LeukemiaThis trial is a limited multi-center, Phase II study to evaluate inotuzumab ozogamicin (Besponsa) in pediatric patients with MRD positive CD22-positive B-lymphoblastic leukemia…NCT03913559·San Diego, California and 1 other

CompletedBlinatumomab & Pembrolizumab for Adults With Relapsed/Refractory B-cell ALL With High Marrow LymphoblastsThis is a Phase I/II study of blinatumomab in combination with pembrolizumab in adult patients with relapsed or refractory B-lineage ALL (B-ALL).NCT03160079·Clovis, California and 3 others

Active not recruitingIbrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell LymphomasThis phase I trial studies the side effect and best dose of ibrutinib in combination with rituximab, etoposide, prednisone, vincristine sulfate, cyclophosphamide, and doxorubicin…NCT03220022·La Jolla, California and 18 others

CompletedSDX-105 in Combination With Rituxan for Patients With Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL)SUMMARY: This is an open label study combining Rituxan and SDX-105. Rituxan will be given on day 1 followed by a 30-60 minute intravenous infusion of SDX-105 on day 2 and day 3.NCT00076349·Anchorage, Alaska and 33 others

CompletedStudy to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With CD20-expressing Hematologic MalignanciesThe purpose of this study is to determine the safety and tolerability of intravenous (IV) and subcutaneous (SC) administration of XmAb13676 and to determine the maximally…NCT02924402·La Jolla, California and 22 others

Active not recruitingTesting CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell LymphomaThis phase II/III trial compares the side effects and activity of oral azacitidine in combination with the standard drug therapy (reduced dose rituximab-cyclophosphamide…NCT04799275·Tucson, Arizona and 175 others

CompletedTREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's DiseaseThis study is designed to determine the effect of 2 gram/day of ethyl-EPA on motor (movement) signs and symptoms of Huntington disease.NCT00146211·Birmingham, Alabama and 40 others

Active not recruitingA Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.The participants of this study would have relapsed/refractory follicular lymphoma. Follicular lymphoma is a type of blood cancer.NCT04224493·Mobile, Alabama and 203 others

Active not recruitingGene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell TransplantThis phase I/II trial studies the side effects and best dose of gene therapy in treating patients with human immunodeficiency virus (HIV)-related lymphoma that did not respond to…NCT02797470·La Jolla, California and 3 others

RecruitingDALY II USA/ MB-CART2019.1 for DLBCLDALY II USA is a phase II, multi-center, single arm study to evaluate the efficacy, safety, and pharmacokinetics of zamtocabtagene autoleucel (MB-CART2019.1) in patients with…NCT04792489·Birmingham, Alabama and 31 others

CompletedTisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin LymphomaThis is a randomized, open label, multicenter phase III trial comparing the efficacy, safety, and tolerability of tisagenlecleucel to Standard Of Care in adult patients with…NCT03570892·La Jolla, California and 66 others

CompletedStudy Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin LymphomaThis study will be separated into 3 distinct phases designated as the Phase 1 study, Phase 2 pivotal study (Cohort 1 and Cohort 2), and Phase 2 safety management study (Cohort 3…NCT02348216·Gilbert, Arizona and 35 others

UnknownXcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) PatientsThis is a Phase II single arm study of a novel T cell immunotherapy in patients with indolent non-Hodgkin's lymphoma (NHL).NCT00081783·Greenbrae, California and 17 others

CompletedBone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603)Bone marrow transplants are one treatment option for people with leukemia or lymphoma.NCT00849147·Duarte, California and 16 others

CompletedDexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic LeukemiaThis randomized phase III trial is studying dexamethasone to see how well it works compared to prednisone during induction therapy.NCT00075725·Birmingham, Alabama and 233 others

Active not recruitingObinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular LymphomaThis phase II trial studies how well obinutuzumab with or without umbralisib, lenalidomide, or combination chemotherapy work in treating patients with grade I-IIIa follicular…NCT03269669·Anchorage, Alaska and 428 others

Active not recruitingA Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic LeukemiaThis phase III trial studies how well blinatumomab works in combination with chemotherapy in treating patients with newly diagnosed, standard risk B-lymphoblastic leukemia or…NCT03914625·Birmingham, Alabama and 227 others

Active not recruitingStudy to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell LymphomaThe purpose of this study is to evaluate the efficacy of loncastuximab tesirine (ADCT-402) combined with rituximab compared to standard immunochemotherapy.NCT04384484·La Jolla, California and 143 others

RecruitingSTimulation to Activate RespIrationMulti-center, randomized, controlled, open-label Phase 2 feasibility trial.NCT06832306·La Jolla, California and 6 others

Page 1 of 7Next

Other Conditions in San Diego

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia